MLN9708
Product Quick Detail
- Place Of Origin
- China
- Minimum Order
- 10
- Packaging
- vial
- Delivery
- 15 Days
Specifications
Product Name: Ixazomib Citrate
Synonyms: 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid;MLN9708;MLN9708,MLN-9708,MLN
9708;4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic
acid;4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid MLN9708;Ixazomib Citrate
CAS: 1201902-80-8
MF: C20H23BCl2N2O9
MW: 517.12162
Product Categories: Apis;Inhibitor
density 1.47
Purity : 99%
Appearance : White powders
Package : 1kg/foil bag
Usage : MLN9708 is the first proteasome inhibitor to be administered in the early stages of multiple myeloma.
- Country:
- Business Type:
- Market:
- Founded Year:
- Address:
- Contact:Jackson Van
Other products from Yuancheng Group
Relate products of MLN9708
MLN9708
Product Name: Ixazomib Citrate Synonyms: 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid;MLN9708;MLN9708,MLN-9708,MLN ...
MLN9708 (Cas No. 1201902-80-8)
MLN9708 immediately hydrolyzed to MLN2238, which is an N-capped dipeptidyl leucine boronic acid and preferentially bound to and inhibited the 20S proteasome with an IC50 value of 3.4 nM (Ki = 0.93 nM). ...
